Efficacy and safety of moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin monotherapy in the treatment of composite cardiovascular events with hypercholesterolemia: A meta-analysis. - Liu, Lingyan; Deng, Yongkun; Li, Lei; Yang, Xingbiao; Yin, Zhaoheng; Lai, Yong (PLoS ONE, 2024)